Stable age pattern supports role of development in unintentional childhood poisoning

M Schmertmann1, A Williamson, D Black

  • 1NSW Injury Risk Management Research Centre, University of New South Wales, Sydney, Australia. mschmertmann@optusnet.com.au

Insights

Child development significantly influences unintentional poisoning risks. Hospitalization rates peak between ages 1-3 years, with boys showing higher risks at age 3. This pattern remains consistent across various demographic factors.

Area of Science:

  • Pediatric epidemiology
  • Child development studies
  • Public health research

Background:

  • Unintentional poisoning is a significant cause of childhood hospitalization.
  • Understanding age-specific risks is crucial for prevention strategies.

Purpose of the Study:

  • To describe hospitalization patterns for unintentional poisoning in children aged 0-4 years in New South Wales.
  • To assess the stability of age-specific poisoning patterns by sex, remoteness, and socioeconomic status.

Main Methods:

  • Retrospective descriptive study using New South Wales hospital data (1994-2005).
  • Analysis of hospitalizations due to unintentional poisoning in children aged 0-4 years.
  • Examination of age-specific hospitalization rates by sex, remoteness, and socioeconomic status.

Main Results:

  • Children aged 1-3 years exhibited the highest hospitalization rates for unintentional poisoning.
  • This age-specific pattern remained consistent over time and across demographic factors.
  • Boys aged 3 years had significantly higher hospitalization rates compared to girls.

Conclusions:

  • The age-specific pattern of unintentional poisoning hospitalizations is stable.
  • Child development plays a critical role in the occurrence of unintentional poisoning events.
  • Findings support targeted prevention efforts based on developmental stages.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...